Clinical trial
Roflumilast Versus Methotrexate in the Treatment of Psoriasis
NCT05684744 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Roflumilast Versus Methotrexate in the Treatment of Psoriasis
- Lead sponsor
- Cairo University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 9, 2023
- Completion date
- May 14, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.